ALPN
Alpine Immune Sciences Inc
Price:  
64.97 
USD
Volume:  
4,285,630.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALPN WACC - Weighted Average Cost of Capital

The WACC of Alpine Immune Sciences Inc (ALPN) is 7.2%.

The Cost of Equity of Alpine Immune Sciences Inc (ALPN) is 8.20%.
The Cost of Debt of Alpine Immune Sciences Inc (ALPN) is 6.15%.

Range Selected
Cost of equity 6.80% - 9.60% 8.20%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.30% - 7.00% 6.15%
WACC 6.0% - 8.3% 7.2%
WACC

ALPN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.60%
Tax rate 0.10% 0.20%
Debt/Equity ratio 1 1
Cost of debt 5.30% 7.00%
After-tax WACC 6.0% 8.3%
Selected WACC 7.2%